Astrazeneca (AZN) Price to FCF (2009 - 2026)

Astrazeneca has reported Price to FCF for 18 years, with the latest figure at 81.01 in Q2 2026.

• On a quarterly basis, Price to FCF rose 51.27% year-over-year to 81.01 in Q2 2026; TTM through Jun 2026 was 17.57, a 26.51% increase from a year earlier, with the FY2025 full-year figure at 16.39, up 11.25% from the prior year.
• Price to FCF was 81.01 for Q2 2026 at Astrazeneca, up from 78.26 in the prior quarter.
• The five-year high for Price to FCF was 136.4 in Q2 2022, with the low at 26.2 in Q4 2023.
• Average Price to FCF over 5 years is 67.52, with a median of 63.55 recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Price to FCF sank 72.68% in 2022, then soared 114.48% in 2024.
• Over 5 years, Price to FCF stood at 28.33 in 2022, then retreated by 7.53% to 26.2 in 2023, then jumped by 114.48% to 56.19 in 2024, then jumped by 50.15% to 84.36 in 2025, then fell by 3.97% to 81.01 in 2026.
• The last three Price to FCF figures came in at 81.01 (Q2 2026), 78.26 (Q1 2026), and 84.36 (Q4 2025), per Business Quant data.